Kommentar zu MSK – Sarkopenie: Muskelreferenzwerte von Th5 bis L3

• Literatur

• 1 Ryan AM, Prado CM, Sullivan ES. et al. Effects of weight loss and sarcopenia on response to chemotherapy, quality of life, and survival.. Nutrition 2019;
• 2 Zhang FM, Song CH, Guo ZQ. et al. Sarcopenia prevalence in patients with cancer and association with adverse prognosis: A nationwide survey on common cancers. Nutrition 2023; 114: 112107
• 3 Cruz-Jentoft AJ, Bahat G, Bauer J. et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019; 48: 16-31
• 4 Blauwhoff-Buskermolen S, Versteeg KS, de van der Schueren MA. et al. Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer. J Clin Oncol 2016; 34: 1339-1344
• 5 Cespedes Feliciano EM, Avrutin E, Caan BJ. et al. Screening for low muscularity in colorectal cancer patients: a valid, clinic-friendly approach that predicts mortality. J Cachexia Sarcopenia Muscle 2018; 9: 898-908
• 6 Lurz E, Patel H, Lebovic G. et al. Paediatric reference values for total psoas muscle area. J Cachexia Sarcopenia Muscle 2020; 11: 405-414
• 7 Schlett CL, Hendel T, Weckbach S. et al. Population-Based Imaging and Radiomics: Rationale and Perspective of the German National Cohort MRI Study. Fortschr Röntgenstr 2016; 188: 652-661